The complementary actions of the antidiabetic agents metformin hydrochloride and rosiglitazone maleate may maintain optimal glycemic control in patients with type 2 diabetes ; therefore , their combined use may be indicated for patients whose diabetes is poorly controlled by metformin alone .
